What Is X-Linked Hypophosphatemia?
Source: Genetic and Rare Diseases (GARD) Information Center
You can contact us here
X-Linked Hypophosphatemia
XLH; X-Linked Hypophosphatemic Rickets; Hypophophatemic Vitamin D-Resistant Rickets; HPDR
X-linked hypophosphatemia (XLH) is an inherited disorder characterized by low levels of phosphate in the blood. Phosphate levels are low because phosphate is abnormally processed in the kidneys, which causes a loss of phosphate in the urine (phosphate wasting) and leads to soft, weak bones (rickets). Explore symptoms, inheritance, genetics of this condition.
Phosphate
Image by Benjah-bmm27
Alkaline Phosphate Molecule
Image by TheVisualMD
Source: Genetic and Rare Diseases (GARD) Information Center
Mutation
Image by AJC1
Source: Genetic and Rare Diseases (GARD) Information Center
Rickets
Image by Nevit Dilmen (talk)
The symptoms of XLH can vary in severity. Some people with XLH have no apparent bone-related symptoms and only hypophosphatemia, while others have severe symptoms. In many cases, symptoms become apparent within the first 18 months of life, when a child begins to bear weight on the legs. Early signs and symptoms may include abnormal bone development (leading to bowing or twisting of the lower legs) and short stature or a slowing growth rate. Other symptoms that may be present early or may develop include:
In some cases, symptoms of XLH do not begin until adulthood. Symptoms that may develop in adults with XLH include joint pain and impaired mobility from enthesopathy (calcification of the tendons, ligaments, and joint capsules), tooth abscesses, and hearing loss.
Source: Genetic and Rare Diseases (GARD) Information Center
X-linked dominant
Image by Autosomal dominant - en.svg: Domaina, Angelito7 and SUM1 Derivative work: SUM1
Source: Genetic and Rare Diseases (GARD) Information Center
Rickets
Image by CDC
XLH is diagnosed based on a physical exam, blood tests, imaging tests such as X-rays, and family history. Specific factors considered for the diagnosis include:
Genetic testing for XLH is available and may confirm the diagnosis if a mutation is identified, but it is not necessary for the diagnosis.
Source: Genetic and Rare Diseases (GARD) Information Center
Surgery
Image by sasint/Pixabay
Source: Genetic and Rare Diseases (GARD) Information Center
Prognosis Icon
Image by mcmurryjulie/Pixabay
XLH is a lifelong condition that may require ongoing treatment and monitoring. While some people with XLH may have only short stature and otherwise good health, there can be significant morbidity associated with XLH as people with the disease get older. This may result from mobility impairment, pain, and discomfort, which may be caused by various complications including osteoarthritis, problems with the tendons and ligaments (enthesopathy) or stress fractures in weakened bones (insufficiency fractures). Furthermore, problems can arise due to incorrect or inadequate treatment or misdiagnosis, since there is a lack of accessible treatment guidelines and awareness of XLH. Additional problems in some people may include:
While starting medical treatment very early in childhood can increase final adult height, it is not yet known whether (or how much) this can prevent later-onset complications, and additional (new) symptoms can develop during adulthood.
Source: Genetic and Rare Diseases (GARD) Information Center
Get free access to in-depth articles and track your personal health.
Send this HealthJournal to your friends or across your social medias.